132 related articles for article (PubMed ID: 11053644)
1. Ukrain(TM), a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines.
Panzer A; Hamel E; Joubert AM; Bianchi PC; Seegers JC
Cancer Lett; 2000 Nov; 160(2):149-57. PubMed ID: 11053644
[TBL] [Abstract][Full Text] [Related]
2. The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro.
Panzer A; Joubert AM; Bianchi PC; Seegers JC
Cancer Lett; 2000 Mar; 150(1):85-92. PubMed ID: 10755391
[TBL] [Abstract][Full Text] [Related]
3. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
4. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
5. Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.
Panzer A; Joubert AM; Eloff JN; Albrecht CF; Erasmus E; Seegers JC
Cancer Lett; 2000 Nov; 160(2):237-41. PubMed ID: 11053654
[TBL] [Abstract][Full Text] [Related]
6. The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways.
Panzer A; Joubert AM; Bianchi PC; Hamel E; Seegers JC
Eur J Cell Biol; 2001 Jan; 80(1):111-8. PubMed ID: 11211931
[TBL] [Abstract][Full Text] [Related]
7. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo investigations on the antitumour activity of Chelidonium majus.
Capistrano I R; Wouters A; Lardon F; Gravekamp C; Apers S; Pieters L
Phytomedicine; 2015 Dec; 22(14):1279-87. PubMed ID: 26626193
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the cytostatic effects of Oliphen and Ukrain.
Voltchek I; Kamyshentsev M; Lavinsky Y; Nowicky J; Medvedev Y; Litvinchuk L
J Chemother; 1996 Apr; 8(2):144-6. PubMed ID: 8708746
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest.
Roublevskaia IN; Haake AR; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):149-56. PubMed ID: 11345021
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
13. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain.
Liepins A; Nowicky JW
Int J Immunopharmacol; 1992 Nov; 14(8):1437-42. PubMed ID: 1464476
[TBL] [Abstract][Full Text] [Related]
14. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
15. Ukrain (NSC-631570) influences on bone status: a review.
Jabłoński M
Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain.
Hohenwarter O; Strutzenberger K; Katinger H; Liepins A; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():1-4. PubMed ID: 1305034
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
Slesak B; Nowicky JW; Harłozinska A
Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
[TBL] [Abstract][Full Text] [Related]
18. Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
Roublevskaia IN; Haake AR; Ludlow JW; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):141-7. PubMed ID: 11345020
[TBL] [Abstract][Full Text] [Related]
19. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro.
Gagliano N; Volpari T; Clerici M; Pettinari L; Barajon I; Portinaro N; Colombo G; Milzani A; Dalle-Donne I; Martinelli C
Anticancer Drugs; 2012 Oct; 23(9):935-46. PubMed ID: 22700003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
